← Leaderboards
Tao Liu
University Of New South Wales
$514,564
Attributed
$568,564
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $125K · FY2007–22$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$568,564 · 4
By mechanism
R03$322,380 · 3
R21$246,184 · 1
Top collaborators
- Glenn M Marshall2 shared
Most similar at University Of New South Wales
Same institution · by research overlap
- Glenn M Marshall$54,000
Others in their field
Top investigators on “Early Childhood”
- James E. Gern · University Of Wisconsin-Madison$146,387,137
- Sharon A Nachman · Johns Hopkins University$74,725,055
- Leonardo Trasande · New York University School Of Medicine$64,009,880
- Elaine D. Eaker · Eaker Epidemiology Enterprises, Llc$63,680,802
- David Heimbrook · Leidos Biomedical Research, Inc.$58,393,265
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$57,178,213
Research focus
Early ChildhoodNeuroblastomaSolid NeoplasmGene ExpressionPlayMalignant NeoplasmsGenetic TranscriptionTumorigenesisOncogenesInhibitor/AntagonistPhosphorylationApoptosisNeuroblastoma CellCell GrowthNeuroblastSerineProtein DegradationClinical TrialsPreventionRelapseHistone DeacetylaseCellsGene RepressionResearch Design
Grant awards (8)
Targeted therapy against TERT oncogene-rearranged neuroblastoma$54,000
R03 · FY2022 · CA · contact PI
Targeted therapy against TERT oncogene-rearranged neuroblastoma$54,000
R03 · FY2021 · CA · contact PI
Eradication of MYCN-amplified neuroblastoma by targeting the interaction between a long noncoding RNA and its binding protein$121,217
R21 · FY2019 · CA · contact PI
Eradication of MYCN-amplified neuroblastoma by targeting the interaction between a long noncoding RNA and its binding protein$124,967
R21 · FY2018 · CA · contact PI
Screening of inhibitors of SIRT1 and SIRT2 for the prevention of neuroblastoma$52,380
R03 · FY2011 · CA · contact PI
Screening of inhibitors of SIRT1 and SIRT2 for the prevention of neuroblastoma$54,000
R03 · FY2010 · CA · contact PI
Prevention of neuroblastoma with histone deacetylase inhibitors$54,000
R03 · FY2008 · CA · contact PI
Prevention of neuroblastoma with histone deacetylase inhibitors$54,000
R03 · FY2007 · CA · contact PI